PIA
NVAX icon

Piedmont Investment Advisors’s Novavax NVAX Stock Holding History

Piedmont Investment Advisors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-606
Closed -$7K – 1152
2019
Q1 		$7K Buy
+606
New +$19.1K ﹤0.01% 1158
2018
Q3 		– Sell
-331
Closed -$9K – 1858
2018
Q2 		$9K Buy
+331
New +$11.2K ﹤0.01% 1874

Other funds holding NVAX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Piedmont Investment Advisors's NVAX Position: Q2 2019 in Review

Piedmont Investment Advisors sold out of Novavax (NVAX) in Q2 2019, closing a stake of 606 shares — an estimated $7K sold.

Piedmont Investment Advisors first reported a position in NVAX in Q2 2018 and held it in 2 quarters. The position peaked at $9K in Q2 2018. 81 funds tracked by Wall St. Rank hold NVAX as of Q2 2019.

  • Piedmont Investment Advisors reported no remaining Novavax position as of Q2 2019 after selling out during the quarter.
  • Piedmont Investment Advisors sold 606 Novavax shares in Q2 2019, an estimated $7K.
  • Piedmont Investment Advisors first reported a position in Novavax in Q2 2018 and held it in 2 quarters.
  • Piedmont Investment Advisors's Novavax position peaked at $9K in Q2 2018.
  • 81 funds tracked by Wall St. Rank held Novavax as of Q2 2019.

Based on Piedmont Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.